rs4895178
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine.
|
30868120 |
2019 |
rs71547482
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine.
|
30868120 |
2019 |
rs9833158
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine.
|
30868120 |
2019 |
rs12204701
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy.
|
30009487 |
2018 |
rs4638568
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies.
|
30531953 |
2018 |
rs4671319
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies.
|
30531953 |
2018 |
rs6432877
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies.
|
30531953 |
2018 |
rs1057516064
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
In silico analysis for predicting pathogenicity of five unclassified mitochondrial DNA mutations associated with mitochondrial cytopathies' phenotypes.
|
28027978 |
2017 |
rs11663316
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs1178326
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs118166657
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs12668095
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs13287547
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs139427007
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs141860749
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs1429264
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs143543475
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs146173241
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs150435906
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs17084405
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs2930491
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs55949311
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs62270313
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs631844
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |
rs71568191
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
|
26220383 |
2015 |